What is the News? EU-AstraZeneca Dispute is taking a new turn. European Union(EU) is taking legal action against AstraZeneca over shortfalls in vaccine deliveries to EU countries. What is the EU-AstraZeneca dispute about? AstraZeneca’s entered into a contract with the European Union. It committed to supplying an initial 300 million doses of vaccine for distribution… Continue reading What is EU-AstraZeneca Dispute?
Tag: vaccine_related_issues
Understanding Herd Immunity and Rising Covid Cases in India
Synopsis: Herd Immunity can’t be attained solely by a rise in Covid-19 positive people. It is also dependent on the absolute number of susceptible individuals and the rate of transmission of the virus. Contents1 Background:2 What is Herd immunity?3 What is a Serological Survey?4 Understanding the current spread: –5 Future Trajectory: Background: The data from… Continue reading Understanding Herd Immunity and Rising Covid Cases in India
The New Vaccine Strategy May Widen Inequality
Synopsis: The new vaccine strategy fails to address the issues of affordability and accessibility. It may contribute to widening inequality in access to health care. Background Recently, the Centre revised its vaccine strategy to accelerate its vaccination drive to bring the Second wave Covid 19 under control. The revised strategies are, One, Vaccine coverage is… Continue reading The New Vaccine Strategy May Widen Inequality
Universal vaccination in India : Challenges and way forward – Explained, Pointwise
Contents1 Introduction2 India’s vaccination policy so far3 Salient features of India’s new vaccination policy4 Other steps taken towards universal vaccination in India5 Need for achieving universal vaccination in India6 Challenges to universal vaccination in the Covid-196.1 Challenges related to affordability:6.2 The issue of vaccine hesitancy: 7 Suggestions to improve universal vaccination in India8 Conclusion Introduction The daily… Continue reading Universal vaccination in India : Challenges and way forward – Explained, Pointwise
Need to Accelerate Vaccination drive
Synopsis: Need to address the issues that issues that are hampering India’s Accelerate Vaccination drive on a priority basis. Background Currently, India is vaccinating more than three million people per day and has administered more than 140 million doses of the vaccine as of April 25, 2021. However, only about 22.3 million (1.63% of India’s… Continue reading Need to Accelerate Vaccination drive
What is “Breakthrough Infection”?
What is the News? The union health ministry has said that the breakthrough infection rate is low for both Covaxin and Covishield vaccines. Contents1 What is it?2 Possible Reasons for Breakthrough Infections:3 India’s Breakthrough Infections Data:4 Concerns: What is it? Breakthrough infection is a case of illness in which a vaccinated individual becomes sick from the… Continue reading What is “Breakthrough Infection”?
Issues in Pricing Mechanism of Covid-19 vaccines
Synopsis: A single price for Covid-19 vaccines will fuel production and ensure efficient vaccination. Introduction Economists suggest market-based solutions for covid-19 vaccines due to their claimed efficiency. The market depends on the price mechanism and the forces of supply and demand. Increased competition pushes up supply and pushes down prices. This combination leads to an… Continue reading Issues in Pricing Mechanism of Covid-19 vaccines
Zydus Cadila’s antiviral drug “Virafin” gets emergency use nod
What is the News? Drug Controller General of India(DCGI) has granted emergency use approval for pharma major Zydus Cadila’s antiviral drug ‘Virafin’ to treat moderate COVID-19 in adults. About Virafin Drug: Virafin is an antiviral drug. It is administered subcutaneously, i.e., it is injected under the skin. “Zydus Cadila”, a pharma major, manufactured. The drug was originally… Continue reading Zydus Cadila’s antiviral drug “Virafin” gets emergency use nod
India’s “New Covid-19 vaccine policy”
What is the News? The Government of India has announced the fourth phase of its New Covid-19 vaccine policy. This phase expands its vaccination coverage to everyone aged 18 and older from May 1. Contents1 Earlier Three Phases:2 Fourth Phase of Covid-19 Vaccine Policy:3 Changes in Distribution:4 Imported Vaccines: Earlier Three Phases: The first three… Continue reading India’s “New Covid-19 vaccine policy”
Roadblocks to achieve universal vaccination
Synopsis: India needs to develop a practical plan, as it is facing many roadblocks to achieve universal vaccination for all. Background Initially, India decided to prioritize vaccination for the most vulnerable citizens (nearly 300 million). The main reason for that were the limitations of India’s manufacturing capacity to provide vaccination to its whole population. Thus,… Continue reading Roadblocks to achieve universal vaccination
